Prostaglandin H synthase and vascular function

Circulation Research

Volumn 89, Issue 8, 2001, Pages 650-660

  Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cyclooxygenase; Eicosanoid; Endothelium; Prostaglandin; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN; IBUPROFEN; ICOSANOID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN H; PROSTAGLANDIN SYNTHASE; THROMBOXANE;

AGING; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CANCER; CHRONIC INFLAMMATION; DIABETES MELLITUS; ENDOTHELIUM; ENZYME LOCALIZATION; HYPERTENSION; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR DISEASE; VASOCONSTRICTION; VASODILATATION;

EID: 0035851212     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh2001.098351     Document Type: Review

References (136)

1. Cyclooxygenases: Structural, cellular, and molecular biology
2. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy
3. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis
4. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
5. Interaction between nitric oxide and prostaglandin H synthase
6. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis
7. Biphasic stimulation of prostacyclin by endogenous nitric oxide (NO) in endothelial cells transfected with inducible NO synthase
8. Differential effects of nitric oxide on the activity of prostaglandin endoperoxide H synthase-1 and -2 in vascular endothelial cells
9. Catalytic consumption of nitric oxide by prostaglandin H synthase-1 regulates platelet function
10. Interactions of oxidants with vascular signaling systems
11. Postischemic generation of superoxide anion by newborn pig brain
12. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2
13. Cyclooxygenase-2 as a therapeutic target
14. Effects of shear stress on eicosanoid gene expression and metabolite production in vascular endothelium as studied in a novel biomechanical perfusion model
15. Characterization of the promoter of human prostaglandin H synthase-1 gene
16. The role of the endothelium in modulating vascular control in sepsis and related conditions
17. Interleukin-1 α stimulated prostacyclin release by increasing gene transcription of prostaglandin H synthase and phospholipase A2 in human vascular endothelial cells
18. Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway
19. Signaling mechanism underlying cox-2 induction by lysophosphatidylcholine
20. Comparative study of vanadate- and phorbol ester-induced cyclooxygenase-2 expression in human endothelial cells
21. Blockade NF-κB activation prohibits TNF-α-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells
22. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium
23. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2
24. Induction of cyclooxygenase-2 by overexpression of the human catalase gene in cerebral microvascular endothelial cells
25. Differential regulation of cyclooxygenase isoenzymes by cAMP-elevating agents
26. Inhibition by extracellular cAMP of phorbol 12-myristate 13-acetate-induced prostaglandin H synthase-2 expression in human pulmonary microvascular endothelial cells: Involvement of an ecto-protein kinase A activity
27. Feedback control of cyclooxygenase-2 expression through PPARγ
28. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
29. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells
30. Post-transcriptional control of cyclooxygenase-2 gene expression: The role of the 3′-untranslated region
31. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
32. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
33. Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta
34. Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells
35. Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells
36. 2 in mixed incubations of endothelial cells and aspirin-treated platelets strongly depends on the prostaglandin I-synthase activity
37. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity
38. Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter
39. Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane
40. Synthesis of 8-epi-prostaglandin F2α by human endothelial cells: Role of prostaglandin H2 synthase
41. Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice
42. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: Role of cyclooxygenase-2 isoform
43. Cyclooxygenase-dependent vasoconstrictor alters vascular function in the vitamin E-deprived rat
44. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: Protective effect of vitamin C
45. Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin
46. Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway
47. 25-Hydroxycholesterol increases eico-sanoids and alters morphology in cultured pulmonary artery smooth muscle and endothelial cells
48. Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells
49. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro
50. 2 in arterioles of hypertensive rats
51. Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclo-oxygenase pathway
52. Changes in the endothelial cyclooxygenase pathway in resistance arteries of spontaneously hypertensive rats
53. Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta
54. Endothelial dysfunction of resistance arteries of spontaneously hypertensive rats
55. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension
56. Increased renal vasoconstriction and gene expression of cyclooxygenase-1 in renovascular hypertension
57. Cyclooxygenases 1 and 2 and thromboxane synthase in kidneys of Lyon hypertensive rats
58. Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat
59. Corcoran Memorial Lecture: The role of eicosanoids in angiotensin-dependent hypertension
60. Impaired endothelial function in transgenic mice expressing both human renin and human angioten-sinogen
61. Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats
62. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence
63. Effects of nitric oxide and cyclooxy-genase inhibition on splanchnic hemodynamics in portal hypertension
64. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: Influence in nitric oxide biosynthesis
65. Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats
66. Vasodilation to acetylcholine in primary and secondary forms of human hypertension
67. Hypertension causes premature aging of endothelial function in humans
68. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension
69. Cyclooxygen-ase inhibition restrores nitric oxide activity in essential hypertension
70. Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium
71. Ontogeny of cyclooxygenase-1 and cyclooxy-genase-2 gene expression in ovine lung
72. Differential role of vasoactive prostanoids in porcine and human isolated pulmonary arteries in response to endothelium-dependent relaxants
73. Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: Role of cyclooxygenase
74. Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats
75. Preeclampsia, what we know and what we do not know
76. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production
77. Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension
78. Role of prostaglandins in pregnancy-induced hypertension
79. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women
80. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women
81. The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia
82. 2 receptor results in intrauterine growth retardation
83. Pregnancy increases ovine uterine artery endothelial cyclooxygenase-1 expression
84. Endothelial vasodilator production by uterine and systemic arteries; IV: Cyclooxygenase isoform expression during the ovarian cycle and pregnancy in sheep
85. Estrogen upregulates cyclooxy-genase-1 gene expression in ovine fetal pulmonary artery endothelium
86. Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries
87. Impairment of vascular function is associated with an age-related increase of lipid peroxidation in rats
88. Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries
89. Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing
90. Prostaglandins, platelets, and atherosclerosis
91. Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries
92. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions
93. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions
94. Future directions in thrombolysis
95. Cyclooxygen-ase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis
96. COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice
97. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state
98. Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TxA2
99. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus
100. Diabetic-induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals
101. Characteristics of coronary endothelial dysfunction in experimental diabetes
102. Adenosine-induced renal vasocon-striction in diabetes mellitus rats: Role of prostaglandins
103. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
104. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects
105. In vivo formation of 8-iso-prostaglandin f2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation
106. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction
107. Free radicals in diabetic endothelial cell dysfunction
108. High glucose enhances IL-1β-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells
109. High glucose concentrations dilate cerebral arteries and diminish myogenic tone through an endothelial mechanism
110. Hyperglycaemia alters the endothelium-dependent relaxation of canine coronary arteries
111. Expression of receptors for advanced glycosylated end-products in renal disease
112. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes
113. The high mobility group (HMG) boxes of the nuclear protein HMGI induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
114. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells
115. Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells
116. Effects of prophylactic low-dose indomethacin on hemodynamics in very low birth weight infants
117. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn
118. Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation
119. Possible role of endothelial thromboxane A2 in the resting tone and contractile responses to acetylcholine and arachidonic acid in canine cerebral arteries
120. Endothelial factors and autoregulation during pressure changes in isolated newborn piglet cerebral arteries
121. Induction of cyclooxygenase-2 following anoxic stress in piglet cerebral arteries
122. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2
123. Cyclooxygen-ase-2 is induced in microglia during chronic cerebral ischemia in humans
124. Cyclooxygen-ase-2 immunoreactivity in the human brain following cerebral ischemia
125. Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex
126. Regulation of cerebral microcirculation-update
127. The relationship between cyclooxygen-ase-2 expression and colorectal cancer
128. 2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
129. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
130. The contributions of cyclooxygenase-2 to tumor angiogenesis
131. 2
132. Cyclooxygenase-2-specific inhibitors: Are they safe?
133. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing
134. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
135. Gene therapy to restore prostacyclin presence to injured endothelium
136. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene